Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Chimeric Peptides from Californiconus californicus and Heterodontus francisci with Antigen-Binding Capacity: A Conotoxin Scaffold to Create Non-Natural Antibodies (NoNaBodies).
Toxins (Basel). 2023 Apr 4;15(4):269. doi: 10.3390/toxins15040269.
Toxins (Basel). 2023.
PMID: 37104207
Free PMC article.
In silico-designed mutations increase variable new-antigen receptor single-domain antibodies for VEGF165 neutralization.
Millán-Gómez D, Dueñas S, Muñoz PLA, Camacho-Villegas T, Elosua C, Cabanillas-Bernal O, Escalante T, Perona A, Abia D, Drescher F, Fournier PGJ, Ramos MA, Mares RE, Paniagua-Solis J, Mata-Gonzalez T, Gonzalez-Canudas J, Hoffman RM, Licea-Navarro A, Sánchez-Campos N.
Millán-Gómez D, et al. Among authors: sanchez campos n.
Oncotarget. 2018 Jun 15;9(46):28016-28029. doi: 10.18632/oncotarget.25549. eCollection 2018 Jun 15.
Oncotarget. 2018.
PMID: 29963259
Free PMC article.
Item in Clipboard
Conotoxin Patenting Trends in Academia and Industry.
Sanchez-Campos N, Bernaldez-Sarabia J, Licea-Navarro AF.
Sanchez-Campos N, et al.
Mar Drugs. 2022 Aug 19;20(8):531. doi: 10.3390/md20080531.
Mar Drugs. 2022.
PMID: 36005534
Free PMC article.
Review.
Item in Clipboard
Potential Therapeutic Applications of Synthetic Conotoxin s-cal14.2b, Derived from Californiconus californicus, for Treating Type 2 Diabetes.
Lugo-Fabres PH, Otero-Sastre LM, Bernáldez-Sarabia J, Camacho-Villegas TA, Sánchez-Campos N, Serrano-Bello J, Medina LA, Muñiz-Hernández S, de la Cruz L, Arenas I, Barajas-Martínez A, Garcia DE, Nuñez-Garcia L, González-Canudas J, Licea-Navarro AF.
Lugo-Fabres PH, et al. Among authors: sanchez campos n.
Biomedicines. 2021 Aug 1;9(8):936. doi: 10.3390/biomedicines9080936.
Biomedicines. 2021.
PMID: 34440140
Free PMC article.
Item in Clipboard
Treatment with metformin glycinate reduces SARS-CoV-2 viral load: An in vitro model and randomized, double-blind, Phase IIb clinical trial.
Ventura-López C, Cervantes-Luevano K, Aguirre-Sánchez JS, Flores-Caballero JC, Alvarez-Delgado C, Bernaldez-Sarabia J, Sánchez-Campos N, Lugo-Sánchez LA, Rodríguez-Vázquez IC, Sander-Padilla JG, Romero-Antonio Y, Arguedas-Núñez MM, González-Canudas J, Licea-Navarro AF.
Ventura-López C, et al. Among authors: sanchez campos n.
Biomed Pharmacother. 2022 Aug;152:113223. doi: 10.1016/j.biopha.2022.113223. Epub 2022 Jun 2.
Biomed Pharmacother. 2022.
PMID: 35709650
Free PMC article.
Clinical Trial.
Item in Clipboard
Unleashing the power of shark variable single domains (VNARs): broadly neutralizing tools for combating SARS-CoV-2.
Cabanillas-Bernal O, Valdovinos-Navarro BJ, Cervantes-Luevano KE, Sanchez-Campos N, Licea-Navarro AF.
Cabanillas-Bernal O, et al. Among authors: sanchez campos n.
Front Immunol. 2023 Sep 11;14:1257042. doi: 10.3389/fimmu.2023.1257042. eCollection 2023.
Front Immunol. 2023.
PMID: 37753081
Free PMC article.
Review.
Item in Clipboard
Cite
Cite